Wiktoria Glanert

Wiktoria Glanert

Auto-generated profile, based on publicly available information

Wiktoria Glanert

Provincial Hospital in Poznań, Juraszów 7/19, 60-479 Poznań Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JBJakub Bajer
Jakub Bajer
AWAleksandra Włodarczyk
Aleksandra Włodarczyk
HKHubert Kulawinek
Hubert Kulawinek
JOJulia Obersztyn
Julia Obersztyn
KKKrzysztof Kasparek
Krzysztof Kasparek
PMPiotr Mrozek
Piotr Mrozek
Background. Post-Traumatic Stress Disorder (PTSD) is an important public health challenge typically treated with trauma-focused psychotherapy and Selective Serotonin Reuptake Inhibitors (SSRIs). However, high rates of residual symptoms associated with these standard treatments have led to a renewed interest in psychedelic-assisted therapies. Aim. This review attempts to examine emerging psychedelic therapies in the management of PTSD, with a primary focus on 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ketamine. Material and methods. A literature search was carried out using PubMed, Google Scholar, and Scopus to identify relevant studies using keywords such as 'PTSD', 'MDMA', 'psychedelics', 'ketamine', 'psychedelic-assisted therapy', 'neuroplasticity', and 'fear extinction'. Results. Psychedelics induce neuroplasticity and augment fear extinction, primarily through the AMPAR-BDNF-TrkB-mTOR pathway and 5-HT2A receptors. MDMA-assisted therapy demonstrates high efficacy, with a trial showing that 67% of participants no longer met PTSD criteria at the study endpoint. Psilocybin effectively treats common comorbidities like anxiety and treatment-resistant depression. Ketamine offers rapid symptom alleviation, making it notably beneficial for treatment-resistant cases with a high risk of self-harm and suicide. Conclusions. Psychedelic therapies, particularly MDMA-assisted therapy, represent a potential breakthrough by targeting the underlying causes of PTSD rather than merely suppressing symptoms. In spite of current regulatory problems, they hold meaningful promise, pointing out the need for standardized treatment protocols to ensure safety and reproducibility in future research.

29 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MCMarta Czech
Marta Czech
JOJulia Obersztyn
Julia Obersztyn
PMPiotr Mrozek
Piotr Mrozek
AMAleksandra Mliczek
Aleksandra Mliczek
HKHubert Kulawinek
Hubert Kulawinek
ASAdrianna Szczecińska
Adrianna Szczecińska
Background. Proper postoperative wound healing is an essential and ongoing component of effective hospital care. Cigarette smoking might be one of the modifiable risk factors for impaired wound healing, which can lead to prolonged hospitalization and increased healthcare costs. Objective. This systematic review examined existing literature on the documented impact of cigarette smoking on the incidence and types of postoperative wound-healing complications by comparing smokers with non-smokers and whether preoperative smoking cessation significantly reduces the risk of these complications. Methods. A structured literature review was conducted using PubMed, Elsevier, ScienceDirect and Scopus were searched between June and August 2026. Studies included systematic reviews, meta-analyses, cohort studies, and review articles published between 2000 and 2025 Results. Smoking cigarettes disrupts the functioning of our body and is associated with numerous disorders and impairs postoperative wound healing. Importantly, these adverse outcomes may be reduced through effective smoking cessation interventions. Conclusion. Smoking cessation before surgery is an important strategy for reducing postoperative complications, healthcare costs, and mortality. Preferably, smoking should be stopped at least 4–6 weeks before elective surgery and continued for 4–8 weeks postoperatively to maximize the potential benefits. Overall, quitting smoking improves surgical outcomes and can be lifesaving.

10 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JOJulia Obersztyn
Julia Obersztyn
ASAdrianna Szczecińska
Adrianna Szczecińska
HKHubert Kulawinek
Hubert Kulawinek
AMAleksandra Mliczek
Aleksandra Mliczek
GKGrzegorz Kasparek
Grzegorz Kasparek
MCMarta Czech
Marta Czech
Introduction: Iron deficiency is one of the most common micronutrient deficiencies in athletes, particularly in endurance athletes and women. The effectiveness of oral iron supplementation depends not only on the dose but also on supplementation timing, dosing frequency, and hepcidin regulation. Aim: To summarize current evidence on oral iron supplementation strategies in athletes, with particular emphasis on the role of hepcidin in optimizing iron absorption. Material and methods: A literature search was conducted through PubMed (MEDLINE) and Google Scholar. Randomized controlled trials, stable-isotope studies, and review articles published in English up to February 2026 were analyzed. Results: Current evidence suggests that alternate-day, low-dose oral iron supplementation improves gastrointestinal tolerance and may enhance iron absorption compared with daily dosing. Iron absorption is influenced by circadian rhythm and exercise-induced increases in hepcidin, making supplementation timing clinically important. Conventional ferrous salts remain the first-line treatment, whereas novel formulations and intravenous iron may be appropriate in selected cases. Conclusions: Iron supplementation should be individualized according to iron status, training schedule, treatment tolerance, and clinical needs. Optimizing dosing frequency and timing represents a simple strategy to improve treatment effectiveness. Further athlete-specific studies are needed to establish evidence-based recommendations.

29 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
GKGrzegorz Kasparek
Grzegorz Kasparek
KKKrzysztof Maksym Kasparek
Krzysztof Maksym Kasparek
JOJulia Obersztyn
Julia Obersztyn
JBJakub Maksymilian Bajer
Jakub Maksymilian Bajer
HKHubert Kulawinek
Hubert Kulawinek
MCMarta Czech
Marta Czech
Erysipelas is an acute bacterial infection of the upper dermis and superficial lymphatic vessels. Beta hemolytic streptococci cause most typical cases. The disease often starts suddenly with painful erythema, warmth, swelling, fever, chills, and a raised or sharply demarcated skin border. Most patients respond to antibiotic therapy, but recurrent episodes can damage lymphatic drainage and create chronic edema. This narrative review summarizes current evidence on etiology, risk factors, clinical variants, diagnosis, treatment, complications, prevention, and care organization. It gives special attention to recurrent lower limb disease, because recurrence links infection with mobility loss, work absence, repeated antibiotic exposure, compression therapy, community nursing, and social support. The review also distinguishes infectious erysipelas from carcinoma erysipeloides, a malignant mimic that can delay cancer diagnosis when clinicians treat persistent erythema as infection.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WGWiktoria Glanert
Wiktoria Glanert
JBJakub Maksymilian Bajer
Jakub Maksymilian Bajer
AWAleksandra Włodarczyk
Aleksandra Włodarczyk
HKHubert Kulawinek
Hubert Kulawinek
JOJulia Obersztyn
Julia Obersztyn
PMPiotr Mrozek
Piotr Mrozek
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that frequently persists into adulthood and is associated with substantial psychiatric comorbidity. Co-occurring mental disorders may complicate diagnosis, worsen functional impairment, and negatively affect treatment outcomes. Objective: This review aimed to summarize and critically analyze current evidence regarding the coexistence of ADHD and other psychiatric disorders in adults, with particular emphasis on depressive disorders, anxiety disorders, bipolar disorder, substance use disorders, sleep disorders, and autism spectrum disorder. Methods: A comprehensive literature search was conducted using PubMed, the NCBI database, and peer-reviewed biomedical journals. Publications from database inception through July 2025 were considered, with particular emphasis on studies published during the preceding ten years. Systematic reviews, meta-analyses, population-based studies, and longitudinal cohorts were prioritized. The review focused on the prevalence, clinical characteristics, potential shared mechanisms, prognostic implications, and treatment considerations associated with psychiatric comorbidity in adult ADHD. Results: Psychiatric comorbidity was identified as a frequent characteristic of adult ADHD, with approximately 60–80% of adults experiencing at least one additional psychiatric disorder during their lifetime. Depressive and anxiety disorders were among the most prevalent comorbidities and were associated with greater functional impairment and reduced quality of life. Bipolar disorder presented important diagnostic challenges due to overlapping symptoms, while substance use disorders were associated with poorer psychosocial outcomes and increased treatment complexity. Sleep disorders were highly prevalent and appeared to interact bidirectionally with ADHD symptoms. The frequent co-occurrence of ADHD and autism spectrum disorder further supports shared neurodevelopmental mechanisms. Emotional dysregulation and executive dysfunction emerged as potential transdiagnostic factors contributing to psychiatric vulnerability. Conclusions: Adult ADHD should be considered a complex, multidimensional disorder that rarely occurs in isolation. Comprehensive assessment of psychiatric comorbidity and integrated, individualized treatment are essential to improve clinical outcomes and quality of life.

8 August 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Mliczek
Aleksandra Mliczek
JOJulia Obersztyn
Julia Obersztyn
ASAdrianna Szczecińska
Adrianna Szczecińska
WGWiktoria Glanert
Wiktoria Glanert
HKHubert Kulawinek
Hubert Kulawinek
MCMarta Czech
Marta Czech
Background: Pulmonary embolism (PE) is a leading cause of maternal morbidity and mortality worldwide. Pregnancy and the postpartum period increase the risk of venous thromboembolism due to hypercoagulability, venous stasis, and endothelial injury. Diagnosis remains challenging because symptoms often overlap with physiological changes in pregnancy, delaying recognition and increasing the risk of adverse outcomes. Aim: To review current evidence on the epidemiology, risk factors, pathophysiology, clinical presentation, diagnosis, and management of pulmonary embolism during pregnancy. Material and methods: A narrative literature review was conducted using publications from PubMed and Scopus, including original studies, systematic reviews, and meta-analyses on pulmonary embolism during pregnancy and the postpartum period. Results: Pulmonary embolism in pregnancy presents significant diagnostic challenges due to nonspecific symptoms and physiological changes affecting clinical assessment. Pregnancy-adapted diagnostic algorithms combining clinical pre-test probability with D-dimer testing may improve diagnostic accuracy while reducing unnecessary imaging. When imaging is required, computed tomography pulmonary angiography and ventilation–perfusion scanning provide high diagnostic performance with acceptable safety. Management is based on risk stratification. Low-molecular-weight heparin is the first-line treatment for hemodynamically stable patients, whereas reperfusion therapies are reserved for high-risk cases. Conclusions: Pulmonary embolism remains a serious pregnancy complication requiring early diagnosis and prompt treatment. Advances in diagnostic strategies and management have improved patient care; however, further studies are needed to optimize risk assessment and treatment in this population.